We came across a bullish thesis on Morgan Stanley on R. Dennis’s Substack by OppCost. In this article, we will summarize the bulls’ thesis on MS. Morgan Stanley’s share was trading at $168.79 as of February 24th. MS’s trailing and forward P/E were 17.59 and 16.05 respectively according to Yahoo Finance.
PTstock/Shutterstock.com
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas and internationally. MS has emerged from a blockbuster earnings season as a premier wealth management powerhouse, with shares trading near $183 on February 9, 2026, up roughly 15% from December lows.
The firm reported record full-year 2025 revenue of $70.6 billion, driven by significant net inflows of $100 billion in the last quarter alone and the successful integration of E*Trade and Eaton Vance, alongside multi-year AI investments that have elevated its operating efficiency.
Amid this momentum, a major institutional trade hit the tape: 10,000 June 18, 2026, $160 puts were sold at $4.80 each, signaling a high-conviction floor for the stock. With the strike price roughly 12.5% below the current market price, the break-even sits at $155.20, which would require a severe macro shock given the firm’s 21.6% ROTCE. This trade reflects both confidence in the company’s resilience and the structural support from its own capital return programs.
Morgan Stanley recently increased its quarterly dividend to $1.00 per share, yielding 2.2%, and reauthorized a $20 billion multi-year buyback program, making the firm itself a synthetic floor for the stock. Coupled with an ongoing Fed rate-cut cycle and accelerating M&A activity, the dynamics suggest strong upside potential while providing a significant margin of safety.
For investors, selling the $160 puts offers a compelling opportunity to get paid while potentially acquiring a world-class compounder at an attractive price, with the stock’s earnings power, wealth management moat, and proactive capital return policy collectively underpinning a robust investment case with asymmetric risk/reward.
Previously, we covered a bullish thesis on JPMorgan Chase & Co. (JPM) by Pacific Northwest Edge in March 2025, which highlighted the bank’s dominant deposit base, strong lending operations, and ability to generate excess capital through buybacks. JPM’s stock price has appreciated by 24.33% since our coverage. OppCost shares a similar view on Morgan Stanley but emphasizes its wealth management expansion, record asset inflows, and capital return programs that provide a built-in floor for the stock.
Morgan Stanley is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 69 hedge fund portfolios held MS at the end of the third quarter which was 67 in the previous quarter. While we acknowledge the risk and potential of MS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than MS and that has 10,000% upside potential, check out our report about this cheapest AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy NOW
Disclosure: None.
